{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017563","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2025-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.494080+00:00","generated_at":"2026-05-18T09:38:31.264416+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Evofem Biosciences issues $1.42M convertible notes and warrants to Aditxt","bullets":["Aggregate principal amount $1,423,076.92; warrants to purchase 92,407,592 shares.","Aditxt paid ~$650 per $1,000 principal; net proceeds ~$925,000.","Notes bear 8% interest (12% upon default), mature June 26, 2028.","Conversion/exercise price $0.0154 per share; 9.99% beneficial ownership cap.","Warrants exercisable immediately, expire in 5 years, allow cashless exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017563","json":"https://secwatch.observer/filing/0001641172-25-017563.json","markdown":"https://secwatch.observer/filing/0001641172-25-017563.md","text":"https://secwatch.observer/filing/0001641172-25-017563.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000164117225017563/0001641172-25-017563-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000164117225017563/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:38:31.264416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}